Business

Antisense and RNAi Therapeutics Sector: Unveiling Market Growth Trends at an 11% CAGR through 2030

/

Antisense and RNAi Therapeutics Sector was valued at US$ 1.63 Bn. in 2023 and is expected to reach US$ 3.38 Bn. […]